Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain.
| Títol: | Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain. |
| Autors: | Falco V; Vallejo-Aparicio LA; Moreno S; Schroeder M; Mackenzie I; Turner M; Harrison C; Rivero A; Torralba M; Ventayol P; Neches V; |
| Investigadors/es (PRC): | Falco Ferrer, Vicenç |
| Publicació relacionada: | Infectious Diseases and Therapy |
| Data de publicació: | 2023 |
| Tipus de document: | Article |
| Publicat a: | Infectious Diseases and Therapy, 2023, p. 1 |
| ISSN: | 2193-8229 |
| DOI: | 10.1007/s40121-023-00840-y |
| Procedència: | Fundació Vall d'Hebron Institut de Recerca |